DDInter948 DDInter1266
Human interferon beta (165 residues), cysteine 17 is substituted with serine. Produced in E. coli, no carbohydrates, MW=18.5kD
Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994. It can effectively manage acute pain as well as pain related to rheumatic diseases, and has a well studied adverse effect profile. Given its overall tolerability and effectiveness, naproxen can be considered a first line treatment for a variety of clinical situations requiring analgesia. Naproxen is available in both immediate and delayed release formulations, in combination with sumatriptan to treat migraines, and in combination with esomeprazole to lower the risk of developing gastric ulcers.
Naproxen {u} (Compound) resembles {v} (Compound) Suprofen
Naproxen {u} (Compound) resembles {v} (Compound) Oxybenzone
Naproxen {u} (Compound) treats {v} (Disease) gout
Naproxen {u} (Compound) binds {v} (Gene) CYP2C9
Naproxen {u} (Compound) upregulates {v} (Gene) FAM63A
Naproxen {u} (Compound) palliates {v} (Disease) osteoarthritis
Naproxen {u} (Compound) is included by {v} (Pharmacologic Class) Nonsteroidal Anti-inflammatory Compounds
Naproxen {u} (Compound) downregulates {v} (Gene) TXLNA
Naproxen {u} (Compound) causes {v} (Side Effect) Muscular weakness
Naproxen {u} (Compound) binds {v} (Gene) and {u} (Compound) upregulates {v} (Gene) PTGS2
Naproxen (Compound) resembles Suprofen (Compound)
Naproxen (Compound) resembles Oxybenzone (Compound)
Naproxen (Compound) treats gout (Disease)
Naproxen (Compound) binds CYP2C9 (Gene)
Naproxen (Compound) upregulates FAM63A (Gene)
Naproxen (Compound) palliates osteoarthritis (Disease)
Naproxen (Compound) is included by Nonsteroidal Anti-inflammatory Compounds (Pharmacologic Class)
Naproxen (Compound) downregulates TXLNA (Gene)
Naproxen (Compound) causes Muscular weakness (Side Effect)
Naproxen (Compound) binds PTGS2 (Gene) and Naproxen (Compound) upregulates PTGS2 (Gene)